Rectal Neoplasms Malignant Clinical Trials

10 clinical trials for Rectal Neoplasms Malignant across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer — RECRUITING · NA
• Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer — RECRUITING · NA
• FAPI in Rectal Cancer TNT — RECRUITING
• CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• A Study on the Efficacy of a Novel Approach to Achieving Laparoscopic Distal Rectal Transection for Rectal Cancers — OTHER · NA
• Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly — COMPLETED · PHASE2
• Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer — OTHER · PHASE3
• Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer — OTHER · PHASE3
• Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer — OTHER · PHASE3

Refine this search